INCR -- Incara Pharmaceuticals | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
INCR -- Incara Pharmaceuticals

An SI Board Since September 2000

Posts	SubjectMarks	Bans	Symbol
196	10	0	INCR

Emcee: scaram(o)uche	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
71	Hey, there are more than just two, and I know tuck is interested too. Happy New	tom pope	-	12/29/2000
70	It's me. And I don't know an antioxidant from a stem cell.	Tomato	-	12/29/2000
69	Hi, "Hey, best of the New Year to you too, as well as to the other two peop	dalroi	-	12/29/2000
68	Guffaw! Hey, best of the New Year to you too, as well as to the other two peopl	scaram(o)uche	-	12/29/2000
67	Very interesting article. As for me...I already look "buff", but must	Arthur Radley	-	12/29/2000
66	Cary: Perhaps relevant to both your question (re. reversal of protein glycosyla	scaram(o)uche	-	12/29/2000
65	Owned Alteon ages ago (1994?), when it was ALTN on NAZ. I haven't looked at	scaram(o)uche	-	12/28/2000
64	MetaPhore Pharmaceuticals Raises Further $13 Million Developing New Class of	scaram(o)uche	-	12/28/2000
63	Thank goodness I was away early today and didn't get an order in for INCR an	Arthur Radley	-	12/26/2000
62	The tax selling in small caps is relentless this year. The ELN deal looks good t	Spekulatius	-	12/26/2000
61	Obviously, I'm going to have to go back and find out what was wrong with my	tom pope	-	12/26/2000
60	TD: >> With that said.... their expertise and money should speed the proc	scaram(o)uche	-	12/24/2000
59	Rick, It does appear that Elan has cut a good deal for themselves, but their his	Arthur Radley	-	12/24/2000
58	Good deal for both parties, leveraged play for Elan. Existing shareholders knew	scaram(o)uche	-	12/23/2000
57	OK, so.... the Knoll obligation is gone. Hurray!! The third project is hoppi	scaram(o)uche	-	12/23/2000
56	OP2000 ------ On December 21, 2000, Incara Pharmaceuticals Corporation	scaram(o)uche	-	12/23/2000
55	Incredibly lame press release. It's as though it was thrown out at the last	scaram(o)uche	-	12/23/2000
54	Incara to Form Partnership With Elan to Develop OP2000; Phase 2/3 Clinical Trial	dalroi	-	12/22/2000
53	Is the connection to INCR's work with anti-oxydants, Rick?	tom pope	-	12/20/2000
52	Message 15053929	scaram(o)uche	-	12/20/2000
51	new stuff from Fridovich et al...... <i>J Biol Chem 2000 Dec 8;275(49):38	scaram(o)uche	-	12/19/2000
50	nice finds, thanks! (eom)	scaram(o)uche	-	12/6/2000
49	Proc. Natl. Acad. Sci. USA, Vol. 97, Issue 25, 13901-13906, December 5, 2000 Ne	tnsaf	-	12/6/2000
48	Incara Announces Fiscal Year 2000 Results RESEARCH TRIANGLE PARK, N.C.,	scaram(o)uche	-	11/28/2000
47	"toxic substances"...... someone will put this sort of study behind	scaram(o)uche	-	11/28/2000

Go to reply# or date (mm/dd/yy):